La vendita allo scoperto per Canaan dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Canaan. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Canaan (NASDAQ:CAN) Azioni, Report sulle vendite allo scoperto

CANAAN INC

Canaan

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.

Canaan Inc

Can B Corp

Tema Oncology ETF

Teucrium Sugar Fund ETV

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma Ltd

Cango Inc. American Depositary Shares, each representing two (2) Class A Ordinary Shares

Cango Inc

CannLabs Inc

Trees Corp

CALIFORNIA NANOTECHS CORP by California Nanotechnologies Corp

California Nanotechnologies Corp

Cano Health Inc Ordinary Shares - Class A

Cano Health Inc Warrants (03/06/2026)

Cian PLC

Calamos Nasdaq Equity & Income ETF

CANAQUEST MED CORP by CanaQuest Medical Corporation

CanaQuest Medical Corp

CANARE ELECTRIC CO LTD by CANARE ELECTRIC CO LTD

Canare Electric Co Ltd

Atlas Energy Corp

Willow Biosciences Inc

CAVENDISH HYDROGEN ASA by CAVENDISH HYDROGEN ASA

News

Market-Moving Exclusives

Exclusives

DFDV

EXCLUSIVE: DeFi Development Tells Benzinga 'DFDV outlined a medium-term objective of reaching 1.0 SPS by December 2028, and near-term guidance of 0.1650 SPS by June 2026, representing approximately 261% growth from today's level of 0.0457'

HC Wainwright &amp; Co. analyst Raghuram Selvaraju downgrades Verona Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNA#NASDAQ">VRNA</a>) from Buy to Neutral and raises the price target from $90 to $107.

Downgrades

Price Target

Analyst Ratings

VRNA

HC Wainwright & Co. Downgrades Verona Pharma to Neutral, Raises Price Target to $107

EXCLUSIVE: DeFi Development Tells Benzinga Co. Sets 1.0 SPS Target By December 2028, Says Issues First Forward Looking Guidance

JP Morgan analyst Andrew Steinerman downgrades Vestis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) from Neutral to Underweight and raises the price target from $5 to $6.

VSTS

JP Morgan Downgrades Vestis to Underweight, Raises Price Target to $6

Evercore ISI Group analyst Robert Ottenstein downgrades Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) from Outperform to In-Line and lowers the price target from $190 to $170.

Evercore ISI Group Downgrades Procter & Gamble to In-Line, Lowers Price Target to $170

MGRM

Trading Halt: Halted at 7:28:57 a.m. ET - Trading Halt: Halt News Pending

Datavault AI Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/DVLT#NASDAQ">DVLT</a>), a pioneer in AI-driven blockchain and data monetization, today announced objectives for the third quarter 2025. The announcement is part of a new discipline of establishing quarterly objectives and reporting on the progress of those objectives to enable the Company's stockholders to track the Company's building and execution of its strategy which includes;
<ul>
<li>Completion of all planned strategic 2025 acquisitions within Acoustic and Data divisions providing avenues for our strategic growth</li>
<li>Brand and launch new International Elements Exchange, International NIL Exchange, and American Politics Exchange leveraging cutting-edge Web 3.0 technologies and high-performance computing systems developed by Datavault AI.</li>
<li>Execution of a Super Computer and AI Development Strategy for 2026 and longer term.</li>
</ul>
Datavault AI's patented Datavalue&#xAE; and DataScore&#xAE; agentic software, developed with engineering and software productization teams at IBM WatsonX. This quarter, upon our team's execution will focus on the exploitation of new patented technology union with NYIAX the Web 3.0 enabled Nasdaq financial framework Datavault AI recently secured through an exclusive license. Additionally, the Information Data Exchanges will be redesigned to enable secure data trading within the same advanced architecture to provide greater scale and reach for Datavault AI global solutions.
Commented Nathaniel T. Bradley, CEO of DataVault AI, "We have an ambitious set of objectives for the upcoming quarter and second half of 2025. We've been working very diligently to assemble an unparalleled set of businesses and assets for a company our size that is intended to enable us to be a leader through various groundbreaking initiatives and solidifying our position as a leader in AI-driven financial technologies related to data monetization, stable and utility coin minting and Sumerian&#xAE; Web 3.0 anchoring." Added Bradley: "We have 3 key objectives for the quarter, they are: (a) the establishment of certain innovative ‘marketplaces' or ‘platforms' to enable the trading of certain innovative stablecoins; (b) establishment of high performance computing and AI development strategy execution (c) the completion of all key strategic acquisitions for the entirety of 2025."
The primary priority for Datavault AI's Q3, will be for the quarter to establish and launch a set of new digital asset platforms that if permitted, will leverage cutting-edge Web 3.0 technologies. A close second and equally as important to our measurement of success is our high-performance supercomputing initiative, that will be powered by Datavault AI's patented Datavalue and DataScore software, developed with engineering and software productization teams at IBM WatsonX. Additionally, the Information Data Exchange will be redesigned to enable secure data trading within the same advanced architecture.
Key patents that are expected to support the Company's efforts include, over 70 unique portfolio holdings and are not limited to a growing portfolio of U.S. and Internationally patents issued, pending and in development, Sumerian Anchors for secure blockchain-based commodity and artifact trading, with specialty in acoustics, DataValue and DataScore for AI-powered valuation and monetization, and NYIAX's blockchain exchange technology make for a diversified portfolio.
"We are entering the next era of digital and data innovation—one that demands trust and a secure, transparent, and automated economy for digital asset trading," said Teri Gallo, CEO of NYIAX. "Datavault AI, NYIAX, and our collective partners are uniquely positioned to deliver the infrastructure required to enable this vision and support the trading of tokenized digital assets across sectors."
The Company plans to actively engage with regulatory authorities to secure the necessary guidance and approval well in advance of the launch of these platforms. Ultimately, the Company's objectives are to facilitate trading of Geo Thermal energy, carbon credits, gold, silver, diamonds, lithium, and rare earth elements in a pre-mining production state, ensuring transparency and efficiency.

DVLT

Datavault AI Plans to Launch Token Trading Platforms and Expand AI-Powered Data Monetization in Q3

JP Morgan analyst Rachel Vatnsdal initiates coverage on Caris Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAI#NASDAQ">CAI</a>) with a Overweight rating and announces Price Target of $31.

Initiation

JP Morgan Initiates Coverage On Caris Life Sciences with Overweight Rating, Announces Price Target of $31

B of A Securities analyst Nafeesa Gupta initiates coverage on Tripadvisor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIP#NASDAQ">TRIP</a>) with a Neutral rating and announces Price Target of $19.

TRIP

B of A Securities Initiates Coverage On Tripadvisor with Neutral Rating, Announces Price Target of $19

B of A Securities analyst Joyce Ju maintains JD.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) with a Buy and lowers the price target from $44 to $37.

B of A Securities Maintains Buy on JD.com, Lowers Price Target to $37

Seaport Global analyst Jeff Cantwell upgrades PayPal Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) from Sell to Neutral.

Upgrades

PYPL

Seaport Global Upgrades PayPal Holdings to Neutral

Baird analyst Colin Sebastian maintains Shopify (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NASDAQ">SHOP</a>) with a Outperform and raises the price target from $110 to $120.

SHOP

Baird Maintains Outperform on Shopify, Raises Price Target to $120

Jefferies analyst Andrew Tsai initiates coverage on BridgeBio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIO#NASDAQ">BBIO</a>) with a Buy rating and announces Price Target of $70.

BBIO

Jefferies Initiates Coverage On BridgeBio Pharma with Buy Rating, Announces Price Target of $70

Baird analyst Richard Eastman maintains Zebra Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>) with a Outperform and raises the price target from $320 to $367.

ZBRA

Baird Maintains Outperform on Zebra Technologies, Raises Price Target to $367

Seaport Global analyst Jeff Cantwell upgrades Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) from Neutral to Buy and maintains the price target from $616 to $616.

Seaport Global Upgrades Mastercard to Buy, Maintains Price Target to $616

Baird analyst Jeff Johnson downgrades Henry Schein (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSIC#NASDAQ">HSIC</a>) from Outperform to Neutral and lowers the price target from $82 to $72.

HSIC

Baird Downgrades Henry Schein to Neutral, Lowers Price Target to $72

Airline begins adding new destinations to its network for the first time since 2021
DALLAS, July 14, 2025 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4467241-1&amp;h=4199715501&amp;u=http%3A%2F%2Fwww.southwest.com%2F%3Fsrc%3DPRPRPRNSTTUSV250714&amp;a=Southwest+Airlines+Co.%C2%A0">Southwest Airlines Co.&nbsp;</a>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) intends to grow its network in 2026 initially with new service at Cyril E. King International Airport (STT) on St. Thomas, adding the U.S. Virgin Islands to the carrier's tropical destinations in the Caribbean. Service is expected to begin in early 2026&#x2A; and will be available for purchase soon.

Southwest Airlines Intends To Grow Network In 2026 Initially With New Caribbean Service To U.S. Virgin Islands

Baird analyst Joe Vruwink upgrades Ncino (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>) from Neutral to Outperform and raises the price target from $30 to $38.

NCNO

Baird Upgrades Ncino to Outperform, Raises Price Target to $38

On July 14, 2025, NextCure, Inc., a Delaware corporation (the "Company"), effected a one-for-twelve (1:12) reverse stock split ("Reverse Stock Split") of the Company's common stock, par value $0.001 (the "Common Stock"). As previously disclosed, at the annual meeting of stockholders of the Company held on June 20, the stockholders of the Company approved an amendment to the Company's Third Amended and Restated Certificate of Incorporation (the "Amendment") to effect a&nbsp;reverse stock split&nbsp;at a ratio in the range of one-to-five (1:5) to one-to-fifteen (1:15), with such ratio to be subsequently determined in the discretion of the Company's board of directors (the "Board").
&nbsp;
Pursuant to such authority granted by the Company's stockholders, the Board approved the&nbsp;Reverse Stock Split&nbsp;of the Common Stock, and the filing of the Amendment to effectuate the&nbsp;Reverse Stock Split. The Amendment became effective at&nbsp;12:01 a.m. Eastern Time on July 14, 2025.
&nbsp;
The Reverse Stock Split will affect all shares of Common Stock outstanding immediately prior to the effective time of the Reverse Stock Split. In addition, the Reverse Stock Split will effect a reduction in the number of shares of Common Stock (i) available for issuance under the Company's 2019 Omnibus Plan and 2019 Employee Stock Purchase Plan, (ii) to be automatically added to the number of shares available for issuance under the 2019 Employee Stock Purchase Plan pursuant to the annual "evergreen" provision of such plan, and (iii) issuable upon the exercise of stock options outstanding immediately prior to the effectiveness of the Reverse Stock Split. To reflect the Reverse Stock Split, there will also be a corresponding increase in the exercise price per share applicable to outstanding stock options. The number of authorized shares of Common Stock will remain at 100 million shares.
&nbsp;
No fractional shares will be issued in connection with the Reverse Stock Split. Stockholders who would otherwise be entitled to a fractional share of Common Stock are instead entitled to a check representing the cash value equal to the fraction to which the stockholder would otherwise be entitled, multiplied by the closing price of the Common Stock, as reported by Nasdaq, on the last trading day prior to the effective date of the Reverse Stock Split.
The Common Stock is scheduled to begin trading on the Nasdaq Global Select Market on a split-adjusted basis when the market opens on July 14, 2025 under the existing ticker symbol "NXTC".

Stock Split

NXTC

NextCure Enacts 1-for-12 Reverse Stock Split, Shares Begin Trading Today on Adjusted Basis

CICC analyst Shiwen Li initiates coverage on Cisco Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) with a Outperform rating and announces Price Target of $78.

Comments

Canaan

Vendite allo scoperto

Canaan (NASDAQ:CAN) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO